Scarica l'app Stockscreener
11.19
0.86%
0.10
Dopo l'orario di chiusura:
11.19
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$11.09
Aprire:
$11.19
Volume 24 ore:
3.75M
Relative Volume:
1.15
Capitalizzazione di mercato:
$1.55B
Reddito:
$4.18B
Utile/perdita netta:
$-1.79B
Rapporto P/E:
-0.8539
EPS:
-13.1048
Flusso di cassa netto:
$107.70M
1 W Prestazione:
+7.65%
1M Prestazione:
+3.28%
6M Prestazione:
-23.34%
1 anno Prestazione:
-58.17%
Intervallo 1D:
$11.05
$11.59
Intervallo di 1 settimana:
$10.21
$11.59
Portata 52W:
$9.225
$28.43
Perrigo Company Plc Stock (PRGO) Company Profile
Nome
Perrigo Company Plc
Settore
Telefono
269-673-8451
Indirizzo
THE SHARP BUILDING, DUBLIN 2
Compare PRGO vs TAK, HLN, TEVA, ZTS, UTHR
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PRGO
Perrigo Company Plc
|
11.19 | 1.53B | 4.18B | -1.79B | 107.70M | -13.10 |
TAK
Takeda Pharmaceutical Co Adr
|
16.96 | 53.37B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
9.84 | 42.80B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
34.65 | 41.09B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
76.29 | 31.62B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
563.70 | 23.23B | 3.17B | 1.29B | 1.01B | 27.09 |
Perrigo Company Plc Stock (PRGO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-11-06 | Downgrade | JP Morgan | Overweight → Neutral |
| 2025-01-14 | Downgrade | Argus | Buy → Hold |
| 2025-01-06 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2024-09-24 | Ripresa | Jefferies | Hold |
| 2023-11-17 | Iniziato | Piper Sandler | Overweight |
| 2023-03-07 | Iniziato | Canaccord Genuity | Buy |
| 2022-09-14 | Aggiornamento | Argus | Hold → Buy |
| 2022-09-06 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2021-10-14 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2021-09-30 | Aggiornamento | Jefferies | Hold → Buy |
| 2021-04-07 | Ripresa | RBC Capital Mkts | Sector Perform |
| 2021-01-06 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-04-17 | Downgrade | Argus | Buy → Hold |
| 2020-03-24 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2020-03-20 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2020-03-18 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2019-10-11 | Aggiornamento | Argus | Hold → Buy |
| 2019-03-20 | Iniziato | SunTrust | Hold |
| 2018-11-13 | Downgrade | Berenberg | Buy → Hold |
| 2018-08-10 | Reiterato | Stifel | Hold |
| 2018-07-30 | Downgrade | Argus | Buy → Hold |
| 2018-07-12 | Downgrade | Goldman | Neutral → Sell |
| 2018-01-03 | Iniziato | Leerink Partners | Mkt Perform |
| 2017-12-08 | Aggiornamento | Argus | Hold → Buy |
| 2017-11-10 | Aggiornamento | RBC Capital Mkts | Underperform → Sector Perform |
| 2017-10-05 | Reiterato | UBS | Buy |
| 2017-09-07 | Iniziato | Oppenheimer | Outperform |
| 2017-08-11 | Aggiornamento | Goldman | Sell → Neutral |
| 2017-08-11 | Reiterato | RBC Capital Mkts | Underperform |
| 2017-06-16 | Iniziato | Cantor Fitzgerald | Overweight |
| 2017-06-05 | Downgrade | RBC Capital Mkts | Sector Perform → Underperform |
| 2017-03-03 | Reiterato | B. Riley & Co. | Neutral |
Mostra tutto
Perrigo Company Plc Borsa (PRGO) Ultime notizie
Enterprise value to revenue forward of Perrigo Company plc – NYSE:PRGO - TradingView
Perrigo Company plc Files Form 8-K for NYSE-Listed Ordinary Shares and Senior Notes – Corporate Details and Security Listings – Minichart - Minichart
Perrigo (PRGO) details interim CEO Albert Manzone’s 2026 pay package - Stock Titan
Perrigo (PRGO) reinstates executive severance policy tied to CEO transition - Stock Titan
Jefferies lowers Perrigo stock price target to $14 on weak quarter - Investing.com
PRGOPerrigo Company plc Options - Finviz
The Store Brand Ibuprofen Tablets from PerrigoB2B pain reliever powering US pharmacy shelves - AD HOC NEWS
Perrigo (PRGO) Shares Surge on M&A Speculation - GuruFocus
Perrigo edges higher amid renewed takeover speculation - MSN
Perrigo Announces Appointment of Two New Independent Directors t - GuruFocus
Perrigo appoints two independent directors to board - Investing.com UK
Perrigo Company plc (PRGO) Announces SEC Filing Details and NYSE Listings – June 30, 2026 - Minichart
Enterprise value to EBIT forward of Perrigo Company plc – NYSE:PRGO - TradingView
Perrigo (NYSE: PRGO) appoints Salman Amin and Omer Gajial to its Board - Stock Titan
Perrigo Announces Appointment of Two New Independent Directors to Board - StreetInsider
Perrigo Company plc Announces Board Appointments, Effective June 30, 2026 - marketscreener.com
Price to sales forward of Perrigo Company plc – NYSE:PRGO - TradingView
Price to earnings forward of Perrigo Company plc – NYSE:PRGO - TradingView
Price to earnings forward of Perrigo Company plc – BOATS:PRGO - TradingView
Compeed Cold Sore Patch from Perrigo Company PLCdiscreet hydrocolloid care for lip herpes - AD HOC NEWS
Perrigo Company plc(NYSE: PRGO) added to Russell 2000 Index - marketscreener.com
Perrigo Company plc(NYSE: PRGO) dropped from Russell Midcap Value Benchmark - marketscreener.com
Perrigo Company plc(NYSE: PRGO) added to Russell 2000 Value Benchmark - marketscreener.com
REGBlackRock GroupSAR 6PERRIGO COMPANY PLC - TradingView
Perrigo Company plc(NYSE: PRGO) dropped from Russell 1000 Value Benchmark - marketscreener.com
Perrigo Company plc(NYSE: PRGO) added to Russell 2000 Dynamic Index - marketscreener.com
Perrigo Company plc(NYSE: PRGO) dropped from Russell 1000 Dynamic Index - marketscreener.com
Compeed Blasenpflaster Extreme from Perrigo Company PLChydrocolloid pads for hard days on your fe - AD HOC NEWS
Perrigo Co. Plc Actuals & Estimates (NYSE:PRGO) - TradingView
Perrigo Company PLC Shs Unsponsored Brazilian Depositary Receipt Repr 1 Sh - TradingView
PRGO Investors Have Opportunity to Lead Perrigo Company plc Class - The National Law Review
PRGO Forecast — Price Target — Prediction for 2027 - TradingView
Perrigo Company PLC (PRGO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Perrigo Co. PLC stock outperforms competitors on strong trading day - MarketWatch
Perrigo Company PLC (PRGO) Valuation: PE, PB & Fair Value Analysis - TradingKey
Perrigo Co. PLC stock underperforms Monday when compared to competitors - MarketWatch
Perrigo Company PLC (PRGO) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Perrigo Company PLC (PRGO) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Perrigo Company PLC (PRGO) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Perrigo Company PLC (PRGO) Institutional Confidence - TradingKey
Perrigo Company PLC (PRGO) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Perrigo Company PLC (PRGO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Perrigo Company PLC (PRGO) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Jim Cramer on Perrigo Comapny: “This Is a Value Trap” - Insider Monkey
Jim Cramer’s 29 Stock Calls and Space Players Worth Watching Like SpaceX and Rocket Lab - Insider Monkey
New protective case elevates everyday use of Perrigo Company PLC medical devices - AD HOC NEWS
Perrigo (PRGO) director reports RSU exercise, tax withholding and 844-unit RSU grant - Stock Titan
Perrigo (PRGO) interim CEO Albert Manzone awarded 1,069 RSUs on shares - Stock Titan
Perrigo (NYSE: PRGO) director logs RSU exercise, tax withholding and 2,559-unit grant - Stock Titan
CFTC Chair Selig Defends U.S. Approval of Perpetual Futures, Citing Robust Regulatory FrameworkUpward Estimate Revision - newsline.com
Price cuts and broader reach put Perrigo’s Nasonex 24HR front and center - AD HOC NEWS
Perrigo Company Plc Azioni (PRGO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Perrigo Company Plc Azioni (PRGO) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Alford Bradley A | Director |
Jun 12 '26 |
Option Exercise |
10.99 |
976 |
10,726 |
45,934 |
| Lockwood-Taylor Patrick | Former CEO and director |
Jun 05 '26 |
Option Exercise |
10.83 |
25,230 |
273,241 |
136,076 |
| Khoury Roberto | EVP and President of CSCI |
Jun 05 '26 |
Option Exercise |
10.83 |
17,902 |
193,879 |
17,433 |
| Willis Robert | EVP & CHRO |
Jun 05 '26 |
Option Exercise |
10.83 |
3,441 |
37,266 |
52,365 |
| Lennox Abigail | EVP and CSO |
Jun 05 '26 |
Option Exercise |
10.83 |
3,823 |
41,403 |
6,603 |
| Bezerra Eduardo Guarita | EVP & Chief Financial Officer |
Jun 05 '26 |
Option Exercise |
10.83 |
9,175 |
99,365 |
86,935 |
| Ball David | EVP & CBDO |
Jun 05 '26 |
Option Exercise |
10.83 |
2,867 |
31,050 |
7,784 |
| Atkinson Charles | EVP, General Counsel & Sec. |
Jun 05 '26 |
Option Exercise |
10.83 |
6,690 |
72,453 |
7,690 |
0.17%
1.98%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):